top of page
  • Writer's pictureANPDF

Azafaros Media Release | December 11, 2023

Azafaros’ Phase 2 RAINBOW study, evaluating nizubaglustat in GM2 and NPC patients, is now fully enrolled

Read the full statement from Azafaros here:

Here is a summary of the article:


To join our fight, as well as fund vital research for a cure, support the Australian NPC Disease Foundation in its goals of "Research. Cure. Persevere."

Ways to support NP-C in Australia:

14 views0 comments


Rated 0 out of 5 stars.
No ratings yet

Add a rating
bottom of page